Single chain antibodies specific to VEGF receptors

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

53038822, C12P 2108, C07K 1600

Patent

active

058745424

ABSTRACT:
Monoclonal antibodies that specifically bind to an extracellular domain of a VEGF receptor and neutralize activation of the receptor are provided. In vitro and in vivo methods of using these antibodies are also provided.

REFERENCES:
patent: 5185438 (1993-02-01), Lemischka
patent: 5270458 (1993-12-01), Lemischka
Folkman, J. and Klagsbrun, M., Angiogenic Factors, Science 235: 442-447 (Jan. 23, 1987).
Kapainen et al., J. Exp. Med 178:2077-2088 (Dec. 1993).
Kim et al., Nature 362:841-844 (Apr. 29, 1993).
Matthews et al., PNAS USA 88:9026-9030 (Oct. 1991).
Millaur et al., Cell 72:835-846 (1993).
Plate et al., Cancer Research 53:5822-5827 (Dec. 1, 1993).
Shibuya et al., Oncogene 5:519-524 (1990).
Terman et al., Oncogene 6:1677-1683 (1991).
Plate, et al., Nature 359, 845-848 (Oct. 1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Single chain antibodies specific to VEGF receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Single chain antibodies specific to VEGF receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single chain antibodies specific to VEGF receptors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-308187

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.